9997.HK Stock Analysis
99
Uncovered
Kangji Medical Holdings Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Market cap $B
0.822
Dividend yield
25.59 %
Shares outstanding
1 189.98 B
Kangji Medical Holdings Ltd. manufactures invasive surgical instruments and accessories. The company is headquartered in Hangzhou, Zhejiang and currently employs 846 full-time employees. The company went IPO on 2020-06-29. The firm's main products include disposable trocars, polymer ligation clips, disposable electrocoagulation forceps and other disposable products, which are used in gynecology and obstetrics, urology, general surgery and thoracic surgery. The firm distributes its products within the domestic market and to overseas markets.